Shana M. Owens

Post-Doctoral Fellow

University of Arkansas for Medical Sciences

postdoc

6 h-index 25 pubs 345 cited

Research Areas

SARS-CoV-2 and COVID-19 Research Immune Response and Inflammation Microbial infections and disease research Herpesvirus Infections and Treatments Health disparities and outcomes T-cell and B-cell Immunology COVID-19 epidemiological studies Viral-associated cancers and disorders

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Shana M. Owens' research investigates viral infections and the immune response, with a significant focus on SARS-CoV-2 and gammaherpesvirus in murine models. Her work has explored the development of autoantibodies following SARS-CoV-2 infection and examined seroprevalence of the virus in Arkansas, including temporal variations by race and ethnicity. She has also contributed to understanding the role of specific cellular pathways, such as STAT3-mediated support, in gammaherpesvirus latency and immune suppression. Owens has published on vaccine efficacy against lytic disease and latency establishment in mice for gammaherpesvirus. Her research network includes extensive collaboration with researchers at the University of Arkansas for Medical Sciences, including J. Craig Forrest, Joshua L. Kennedy, Catherine Kirkpatrick, and Marianne Kouassi. Her scholarship metrics include an h-index of 6, with 25 total publications and 345 total citations.

Metrics

h-index: 6
Publications: 25
Citations: 345

Selected Publications

The amplitude of gammaherpesvirus lytic replication dictates adaptive immune activation: Potential implications for KSHV LANA in immune evasion (2026) DOI
Intrinsic p53 activation restricts gammaherpesvirus driven germinal center B cell expansion during latency establishment (2025) DOI
A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment (2024) DOI
Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through in vivo B cell knockout models (2024) DOI
Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice (2023) DOI
B cell-intrinsic STAT3-mediated support of latency and interferon suppression during murine gammaherpesvirus 68 infection revealed through an in vivo competition model (2023) DOI
Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency In Vivo (2022) DOI
Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas (2022) DOI
Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic (2022) DOI
Development of ACE2 autoantibodies after SARS-CoV-2 infection (2021) DOI
Lytic Replication and Reactivation from B Cells Is Not Required for Maintaining Gammaherpesvirus Latency in vivo (2021) DOI
Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic (2021) DOI
Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas (2021) DOI